← Leaderboards
Yue Xiong
University Of North Carolina Chapel Hill
$19,134,640
Attributed
$20,198,640
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$20,198,640 · 8
By mechanism
R01$17,817,198 · 5
P30$2,381,442 · 3
Top collaborators
- Lishan Su4 shared
Others in their field
Top investigators on “Regulation”
- Kiyoshi Suyehiro · Iodp Management International, Inc$166,539,344
- David Heimbrook · Leidos Biomedical Research, Inc.$152,164,826
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Nevan J Krogan · University Of California, San Francisco$101,337,442
- Asimah Rafi · Technical Resources Inc$95,881,052
- Richard C Boucher · University Of North Carolina Chapel Hill$83,460,414
Research focus
RegulationFundingCellsPathway InteractionsFamilyUbiquitinBaseInvestigationGenesTumor SuppressionBackResearch PersonnelUbiquitin-Protein LigaseEpigenetic ProcessComplexProteinsTumorInsightAreaMalignant NeoplasmsCell Cycle RegulationChromatinMutationApoptosis
Grant awards (76)
Cancer Cell Biology Research Program (Program 1)$38,649
P30 · FY2020 · CA · contact PI
HIV-1 Vpr disrupts the IFN-TET-ISG pathway to promote HIV-1 infection and persistence$532,000
R01 · FY2019 · AI
Epigenetic Control by Ubiquitylation$385,524
R01 · FY2019 · GM · contact PI
Maintaining Genome Integrity and Suppressing Tumorigenesis by the 3M-CUL7-CUL9-p53$335,361
R01 · FY2019 · CA · contact PI
Cancer Cell Biology Research Program (Program 1)$37,462
P30 · FY2019 · CA · contact PI
HIV-1 Vpr disrupts the IFN-TET-ISG pathway to promote HIV-1 infection and persistence$532,000
R01 · FY2018 · AI
Epigenetic Control by Ubiquitylation$385,524
R01 · FY2018 · GM · contact PI
Maintaining Genome Integrity and Suppressing Tumorigenesis by the 3M-CUL7-CUL9-p53$345,734
R01 · FY2018 · CA · contact PI
Epigenetic Control by Ubiquitylation$99,947
R01 · FY2018 · GM · contact PI
Cancer Cell Biology Research Program (Program 1)$38,646
P30 · FY2018 · CA · contact PI
Cancer Cell Biology Research Program (Program 1)$2,968
P30 · FY2018 · CA · contact PI
Cancer Cell Biology Research Program (Program 1)$2,101
P30 · FY2018 · CA · contact PI
Cancer Cell Biology Research Program (Program 1)$1,366
P30 · FY2018 · CA · contact PI
HIV-1 Vpr disrupts the IFN-TET-ISG pathway to promote HIV-1 infection and persistence$532,000
R01 · FY2017 · AI
Epigenetic Control by Ubiquitylation$385,524
R01 · FY2017 · GM · contact PI
Maintaining Genome Integrity and Suppressing Tumorigenesis by the 3M-CUL7-CUL9-p53$345,734
R01 · FY2017 · CA · contact PI
Control of Microtubule and Genome Integrity by the OBSL1-CUL7-CUL9-p53 Pathway$70,268
R01 · FY2017 · CA · contact PI
Cancer Cell Biology Research Program (Program 1)$37,914
P30 · FY2017 · CA · contact PI
HIV-1 Vpr disrupts the IFN-TET-ISG pathway to promote HIV-1 infection and persistence$532,000
R01 · FY2016 · AI
Epigenetic Control by Ubiquitylation$385,524
R01 · FY2016 · GM · contact PI
Control of Microtubule and Genome Integrity by the OBSL1-CUL7-CUL9-p53 Pathway$332,383
R01 · FY2016 · CA · contact PI
Mechanisms of Metabolic Gene Mutations in Cancer$307,100
R01 · FY2016 · CA · contact PI
Cancer Cell Biology Research Program (Program 1)$38,144
P30 · FY2016 · CA · contact PI
Control of Microtubule and Genome Integrity by the OBSL1-CUL7-CUL9-p53 Pathway$332,383
R01 · FY2015 · CA · contact PI
Mechanisms of Metabolic Gene Mutations in Cancer$307,100
R01 · FY2015 · CA · contact PI
Program Leaders$253,715
P30 · FY2015 · CA · contact PI
Cancer Cell Biology$173,149
P30 · FY2015 · CA · contact PI
Function and Mechanism of CUL4 E3 Ligases in Human Diseases$358,269
R01 · FY2014 · GM · contact PI
Control of Microtubule and Genome Integrity by the OBSL1-CUL7-CUL9-p53 Pathway$322,412
R01 · FY2014 · CA · contact PI
Mechanisms of Metabolic Gene Mutations in Cancer$297,887
R01 · FY2014 · CA · contact PI
Program Leaders$250,926
P30 · FY2014 · CA · contact PI
Cancer Cell Biology$163,459
P30 · FY2014 · CA · contact PI
Function and Mechanism of CUL4 E3 Ligases in Human Diseases$345,670
R01 · FY2013 · GM · contact PI
Control of Microtubule and Genome Integrity by the OBSL1-CUL7-CUL9-p53 Pathway$312,440
R01 · FY2013 · CA · contact PI
Mechanisms of Metabolic Gene Mutations in Cancer$288,674
R01 · FY2013 · CA · contact PI
Program Leaders$255,532
P30 · FY2013 · CA · contact PI
Cancer Cell Biology$170,077
P30 · FY2013 · CA · contact PI
Function and Mechanism of CUL4 E3 Ligases in Human Diseases$358,142
R01 · FY2012 · GM · contact PI
Mechanisms of Metabolic Gene Mutations in Cancer$357,100
R01 · FY2012 · CA · contact PI
Control of Microtubule and Genome Integrity by the OBSL1-CUL7-CUL9-p53 Pathway$332,383
R01 · FY2012 · CA · contact PI
Program Leaders$265,545
P30 · FY2012 · CA · contact PI
Cancer Cell Biology$187,175
P30 · FY2012 · CA · contact PI
Program Leaders$2,554
P30 · FY2012 · CA · contact PI
Cancer Cell Biology$2,552
P30 · FY2012 · CA · contact PI
Function and Mechanism of CUL4 E3 Ligases in Human Diseases$358,079
R01 · FY2011 · GM · contact PI
Program Leaders$271,762
P30 · FY2011 · CA · contact PI
Cancer Cell Biology$187,746
P30 · FY2011 · CA · contact PI
The Physiological Function and Regulation of INK4 Genes$326,778
R01 · FY2010 · CA · contact PI
The Cullin-ROC Family of E3 Ubiquitin Ligases$322,788
R01 · FY2010 · GM · contact PI
The Cullin-ROC Family of E3 Ubiquitin Ligases$91,024
R01 · FY2010 · GM · contact PI
The Physiological Function and Regulation of INK4 Genes$348,264
R01 · FY2009 · CA · contact PI
The Physiological Function and Regulation of INK4 Genes$320,372
R01 · FY2009 · CA · contact PI
The Cullin-ROC Family of E3 Ubiquitin Ligases$316,567
R01 · FY2009 · GM · contact PI
The Mammalian Cell Cycle Control and Tumor Genesis$294,172
R01 · FY2009 · CA · contact PI
The Physiological Function and Regulation of INK4 Genes$311,040
R01 · FY2008 · CA · contact PI
The Cullin-ROC Family of E3 Ubiquitin Ligases$307,357
R01 · FY2008 · GM · contact PI
The Mammalian Cell Cycle Control and Tumor Genesis$294,172
R01 · FY2008 · CA · contact PI
The Physiological Function and Regulation of INK4 Genes$307,961
R01 · FY2007 · CA · contact PI
The Cullin-ROC Family of E3 Ubiquitin Ligases$307,331
R01 · FY2007 · GM · contact PI
The Mammalian Cell Cycle Control and Tumor Genesis$294,173
R01 · FY2007 · CA · contact PI
The Mammalian Cell Cycle Control and Tumor Genesis$302,959
R01 · FY2006 · CA · contact PI
The ROC-Cullin Family of E3 Ubiquitin Ligases$253,842
R01 · FY2006 · GM · contact PI
The Mammalian Cell Cycle Control and Tumor Genesis$310,250
R01 · FY2005 · CA
INK4 FAMILY OF CDK INHIBITORS$300,211
R01 · FY2005 · CA
The ROC-Cullin Family of E3 Ubiquitin Ligases$259,951
R01 · FY2005 · GM
INK4 FAMILY OF CDK INHIBITORS$300,211
R01 · FY2004 · CA
MAMMALIAN CELL CYCLE CONTROL AND TUMOROGENESIS$285,856
R01 · FY2004 · CA
The ROC-Cullin Family of E3 Ubiquitin Ligases$259,951
R01 · FY2004 · GM
INK4 FAMILY OF CDK INHIBITORS$300,211
R01 · FY2003 · CA
MAMMALIAN CELL CYCLE CONTROL AND TUMOROGENESIS$277,530
R01 · FY2003 · CA
The ROC-Cullin Family of E3 Ubiquitin Ligases$257,494
R01 · FY2003 · GM
INK4 FAMILY OF CDK INHIBITORS$300,211
R01 · FY2002 · CA
MAMMALIAN CELL CYCLE CONTROL AND TUMOROGENESIS$269,447
R01 · FY2002 · CA
INK4 FAMILY OF CDK INHIBITORS$299,786
R01 · FY2001 · CA
MAMMALIAN CELL CYCLE CONTROL AND TUMOROGENESIS$261,598
R01 · FY2001 · CA
MAMMALIAN CELL CYCLE CONTROL AND TUMOROGENESIS$258,529
R01 · FY2000 · CA